381
Participants
Start Date
April 30, 2009
Primary Completion Date
October 31, 2010
Study Completion Date
November 30, 2010
Placebo
Placebo
IPX066 95 mg LD
IPX066 capsule containing 95 mg LD/23.75 mg CD
IPX066 145 mg LD
IPX066 capsule containing 145 mg LD/36.25 mg CD
IPX066 195 mg LD
IPX066 capsule containing 195 mg LD/48.75 mg CD
IPX066 245 mg LD
IPX066 capsule containing 245 mg LD/61.25 mg CD
P.Stradina university hospital, Riga
Mount Sinai School of Medicine, New York
Columbia University, New York
East Tallinn Central Hospital, Tallinn
West Tallin Central Hopsital, Tallinn
State University of New York Upstate Medical University, Dept. of Neurology, Syracuse
Neurology department of Vinnitsa Medical University, Vinnitsa
Sunrise Clinical Research, Inc., Hollywood
Duke University Medical Center Movement Disorders Center, Durham
University of South Florida, Tampa
Suncoast Neuroscience Associates, Inc., St. Petersburg
Charlotte Neurological Services, Port Charlotte
Bradenton Research Center, Inc., Bradenton
Renstar Medical Research, Ocala
University of Alabama at Birmingham, Dept. of Neurology, Birmingham
Neurology department of Medical Dental Academy based on Poltava regional hospital, Poltava
University of Toledo, Toledo
Quest Research Institute, Bingham Farms
Neurology department of Regional hospital named after Mechnikov, Dnipro
Wisconsin Institute for Neurologic and Sleep Disorders, Milwaukee
Struthers Parkinson's Center, Golden Valley
Rush University Medical Center, Dept. of Neurological Sciences, Chicago
Neurology department, Zaporozhye State Medical University, Zaporizhzhya
Baylor College of Medicine, Parkinson's Disease Center, Houston
Neurology department of Lviv regional clinical hospital, Lviv
Department of Psychiatry and Medical Psychology of Donetsk National Medical University, Donetsk
Department of Neurological Diseases and Medical Genetic of Donetsk National Medical University, Donetsk
Idaho Elks Rehabilitation Hospital, Boise
HOPE Research Institute, LLC, Phoenix
Coastal Neurological Medical Group, La Jolla
Coordinated Clinical Research, La Jolla
Collaborative NeuroScience Network, Inc., Garden Grove
The Parkinson's Institute, Sunnyvale
County Clinical Emergency Hospital Timisoara, Timișoara
County Emergency Clinical Hospital Cluj-Napoca, I Neurology Clinic, Cluj-Napoca
Psychiatry and Neurology Hospital, Neurology Department, Brasov
County Clinical Emergency Hospital, Targu Mures, II Neurology Department,, Târgu Mureş
CFR Clinical Hospital Constanta, Constanța
Yale Neurology Clinics, Temple Medical Center, New Haven
Landon Center on Aging, Dept. of Neurology, Parkinson's Disease Center, Kansas City
Boston University School of Medicine, Boston
UMDNJ Robert Wood Johnson Medical Center, Department of Neurology, New Brunswick
Movement Disorders Clinic, Glenrose Rehabilitation Hospital, Edmonton
Saint Boniface Clinic, Winnipeg
London Health Science Center, London
Parkinson's and Neurodegenerative Disorders Clinic, Ottawa
Ottawa Hospital Civic Site, Ottawa
Toronto Western Hospital, Toronto
Memory and Motor Skills Clinic, Québec
University of Sherbrooke, Sherbrooke
Gailezers hospital, Riga
Clinical Rehabilitation Hospital Iasi, Neurology Department, Iași
Kaunas Medical University Hospital, Kaunas
Siauliai Regional Hospital, Šiauliai
Vilnius University Emergency Hospital, Vilnius
Vilnius University Centre of Gerontology and Rehabilitation, Vilnius
Vilnius University Hospital Santariskiu klinikos, Vilnius
Colentina Clinical Hospital Bucharest, II Neurology Department, Bucharest
1st neurology department of Central Clinical Hospital of Ukrzaliznytsya, Kharkiv
Institute of Gerontology Parkinson's Disease Center, Kiev
Lead Sponsor
Impax Laboratories, LLC
INDUSTRY